​

Liminatus Pharma Ownership | Who Owns Liminatus Pharma?

OverviewFinancialsChart

Liminatus Pharma Ownership Summary

Liminatus Pharma is owned by 6.21% institutional investors, 38.53% insiders, and 55.26% retail investors. Two sigma securities is the largest institutional shareholder, holding 0% of LIMN shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.19% of its assets in Liminatus Pharma shares.

LIMN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockLiminatus Pharma6.21%38.53%55.26%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Two sigma securities---
Jane street group---
Virtu financial---
Farther finance advisors---
Citigroup---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Two sigma securities---
Jane street group---
Virtu financial---
Farther finance advisors---
Citigroup---

Top Buyers

HolderShares% AssetsChange
Farther finance advisors---14.00
Citigroup---6.77K
Two sigma securities---22.04K
Virtu financial---27.47K
Jane street group---71.32K

Top Sellers

HolderShares% AssetsChange
Jane street group---71.32K
Virtu financial---27.47K
Two sigma securities---22.04K
Citigroup---6.77K
Farther finance advisors---14.00

Sold Out

HolderChange
Farther finance advisors-14.00
Citigroup-6.77K
Two sigma securities-22.04K
Virtu financial-27.47K
Jane street group-71.32K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20261525.00%1,475,438365.15%6348.35%1183.33%350.00%
Dec 31, 20251220.00%317,19321.10%1141.98%6-2100.00%
Sep 30, 202510-261,92427.95%-125.66%6-40.00%1-
Jun 30, 202510-204,702---10---

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr50.44K0.19%-
Fidelity Extended Market Index120.45K0.18%43.15K
Fidelity Nasdaq Composite Index16.77K0.06%-
Blackrock Extended Mkt Fund CF12.94K0.05%-
Extended Equity Market Fund E12.94K0.03%-
Extended Equity Market Fund B12.94K0.03%-
BlackRock Extended Equity Market Fund K11.02K0.02%-81.00
NT Ext Equity Mkt Index Fund - Lending4.50K0.02%-
NT Ext Equity Mkt Index Fund - NL3.70K0.01%-
Spartan Total Market Index Pool G3.62K0.01%-

Insider Transactions Trends

DateBuySell
2025 Q2--

LIMN Ownership FAQ

Who Owns Liminatus Pharma?

Liminatus Pharma shareholders are primarily institutional investors at 6.21%, followed by 38.53% insiders and 55.26% retail investors. The average institutional ownership in Liminatus Pharma's industry, Biotech Stocks , is 35.43%, which Liminatus Pharma falls below.

Who owns the most shares of Liminatus Pharma?

Liminatus Pharma’s largest shareholders are Two sigma securities (0 shares, 0%), Jane street group (0 shares, 0%), and Virtu financial (0 shares, 0%). Together, they hold 0% of Liminatus Pharma’s total shares outstanding.

Does Blackrock own Liminatus Pharma?

BlackRock is not among the top 10 institutional shareholders of Liminatus Pharma.

Who is Liminatus Pharma’s biggest shareholder by percentage of total assets invested?

Two sigma securities is Liminatus Pharma’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Liminatus Pharma shares, valued at 0$.

Who is the top mutual fund holder of Liminatus Pharma shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Liminatus Pharma shares, with 0.19% of its total shares outstanding invested in 50.44K Liminatus Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools